Growing community of inventors

San Francisco, CA, United States of America

Jeffrey Wu

Average Co-Inventor Count = 6.67

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Jeffrey WuJeffrey Thomas Mihalic (2 patents)Jeffrey WuJoel McIntosh (2 patents)Jeffrey WuArthur T Sands (2 patents)Jeffrey WuDahlia Weiss (2 patents)Jeffrey WuDaniel W Robbins (2 patents)Jeffrey WuDaisuke Kato (2 patents)Jeffrey WuGe Peng (2 patents)Jeffrey WuJohn Lee (1 patent)Jeffrey WuKerem Ozboya (1 patent)Jeffrey WuWylie Palmer (1 patent)Jeffrey WuTim Kane (1 patent)Jeffrey WuJohn Lee (1 patent)Jeffrey WuJeffrey Wu (3 patents)Jeffrey Thomas MihalicJeffrey Thomas Mihalic (32 patents)Joel McIntoshJoel McIntosh (14 patents)Arthur T SandsArthur T Sands (11 patents)Dahlia WeissDahlia Weiss (8 patents)Daniel W RobbinsDaniel W Robbins (2 patents)Daisuke KatoDaisuke Kato (2 patents)Ge PengGe Peng (2 patents)John LeeJohn Lee (63 patents)Kerem OzboyaKerem Ozboya (1 patent)Wylie PalmerWylie Palmer (1 patent)Tim KaneTim Kane (1 patent)John LeeJohn Lee (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Nurix Therapeutics, Inc. (2 from 14 patents)

2. Gilead Sciences, Inc. (1 from 924 patents)


3 patents:

1. 11976071 - Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases

2. 11866442 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

3. 11479556 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…